Viking Therapeutics Stock Price - VKTX

0.01 (0.23%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Viking Therapeutics Inc VKTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.09 -2.0% 4.40 4.31 4.58 4.48 4.49 00:00:05
Bid Price Ask Price Spread Spread % News
3.50 4.55 1.05 23.08% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,795 917,493 $ 4.41 $ 4,049,217 1,740,257 3.26 - 11.0294
Last Trade Time Type Quantity Stock Price Currency
19:55:53 10 $ 4.41 USD

Viking Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 319.28M 72.56M $ -22.06M -0.37 - 69.63M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Viking Therapeutics News

Loading Messages....

Latest VKTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VKTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.644.804.304.541,311,517-0.24-5.17%
1 Month5.515.753.264.361,751,230-1.11-20.15%
3 Months7.747.783.265.561,367,490-3.34-43.15%
6 Months6.978.873.266.531,314,385-2.57-36.87%
1 Year10.2411.02943.267.441,470,072-5.84-57.03%
3 Years1.4624.000.889.431,854,1152.94201.37%
5 Years8.5024.000.888.931,205,571-4.10-48.24%

Viking Therapeutics Description

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Your Recent History
Viking The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.